Teva Pharmaceutical Industries (TEV) Stock Rating Reaffirmed by TD Securities

TD Securities reiterated their buy rating on shares of Teva Pharmaceutical Industries (FRA:TEV) in a research note published on Monday morning. The firm currently has a $10.00 target price on the stock.

Teva Pharmaceutical Industries Company Profile

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines and a portfolio of specialty medicines worldwide. It operates through two segments, Generic Medicines and Specialty Medicines. The Generic Medicines segment offers sterile products, hormones, narcotics, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams.

Read More: Fundamental Analysis – How It Helps Investors

Receive News & Ratings for Teva Pharmaceutical Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teva Pharmaceutical Industries and related companies with's FREE daily email newsletter.

Leave a Reply